Vaccines
Latest News
RNA Vaccines: Risk for Heavy Menstrual Bleeding Clarified
French study provides new evidence for an increased risk for heavy menstrual bleeding following COVID-19 vaccination with mRNA vaccines.
News
Microbiome Impacts Vaccine Responses
A major factor affecting immune development is the microbiome of the newborn and the first 100 days of life.
From the Journals
HPV Vaccine Shown to Be Highly Effective in Girls Years Later
Researchers correlated the rate of cervical cancer per 100,000 person-years with data on women regarding vaccination status, age when vaccinated,...
Latest News
Rubella Screening in Pregnancy No Longer Recommended in Italy
The elimination of the endemic transmission of rubella in Italy prompted a reconsideration of the country’s pregnancy guidelines.
Latest News
Coming Soon: The First mRNA Vaccine for Melanoma?
Phase 2 trial results promising for mRNA vaccine for melanoma.
Latest News
Shingles Vaccine Offers 4 Years of Protection
People who received two doses of the vaccine, regardless of when they received their second dose, experienced 79% vaccine effectiveness during the...
Latest News
The 2024 Adult Vaccine Schedule Changes Are Here
The newest vaccine additions to the 2024 schedule include RSV vaccines, the mpox vaccine, a new MenACWY-MenB combo vaccine, and the new 2023-2024...
Latest News
Some reasons to get off the fence about COVID booster
“The body of evidence from all these different studies converge on one single reality — that vaccines reduce the risk of long COVID.”
News from the FDA/CDC
Global measles deaths increased by 43% in 2022
The report also notes an increase in the number of countries experiencing significant measles outbreaks. There were 37 such countries in 2022,...
From the Journals
COVID vaccines lower risk of serious illness in children
“The findings in this report support the recommendation for COVID-19 vaccination for all children aged ≥6 months and highlight the importance of...
From the Journals
COVID vaccination protects B cell–deficient patients through T-cell responses
The findings demonstrate how vaccine-induced T-cell responses could potentially reduce COVID-19 severity, the authors write.